These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31137010)

  • 1. MANAGEMENT OF ENDOCRINE DISEASE: Predictive scores in autoimmune thyroid disease: are they useful?
    Effraimidis G
    Eur J Endocrinol; 2019 Sep; 181(3):R119-R131. PubMed ID: 31137010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
    Masiello E; Veronesi G; Gallo D; Premoli P; Bianconi E; Rosetti S; Cusini C; Sabatino J; Ippolito S; Piantanida E; Tanda ML; Chiovato L; Wiersinga WM; Bartalena L
    J Endocrinol Invest; 2018 Dec; 41(12):1425-1432. PubMed ID: 29946800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.
    Strieder TG; Tijssen JG; Wenzel BE; Endert E; Wiersinga WM
    Arch Intern Med; 2008 Aug; 168(15):1657-63. PubMed ID: 18695079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism.
    Wiersinga W; Žarković M; Bartalena L; Donati S; Perros P; Okosieme O; Morris D; Fichter N; Lareida J; von Arx G; Daumerie C; Burlacu MC; Kahaly G; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
    Eur J Endocrinol; 2018 Jun; 178(6):635-643. PubMed ID: 29650691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases.
    Zaaber I; Rancier M; Stathopoulou MG; Saleh A; Marmouch H; Masson C; Murray H; Kurth MJ; Lamont J; Fitzgerald P; Mahjoub S; Said K; Bel Hadj Jrad Tensaout B; Mestiri S; Visvikis-Siest S
    Autoimmunity; 2016 Jun; 49(4):229-35. PubMed ID: 26955881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases (.).
    Bossowski A; Moniuszko M; Idźkowska E; Grubczak K; Singh P; Bossowska A; Diana T; Kahaly GJ
    Autoimmunity; 2016 Aug; 49(5):320-8. PubMed ID: 27206624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current thyroid diagnostics and therapy in disorders of fertility and in pregnancy].
    Fink HJ; Hintze G
    Med Klin (Munich); 2006 Aug; 101(8):645-52; quiz 653-4. PubMed ID: 16896571
    [No Abstract]   [Full Text] [Related]  

  • 9. Are pituitary and thyroid function tests useful for the monitoring of antithyroid drug treatment and the post therapeutic control of Graves' disease?
    Jaffiol C; Baldet L; Castelnau P; Papachristou C; Lapinski H; Rouaud R
    Horm Res; 1987; 26(1-4):137-45. PubMed ID: 2439427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary Alterations in Autoimmune Thyroid Diseases: A Systematic Review.
    Ortarzewska M; Nijakowski K; Kolasińska J; Gruszczyński D; Ruchała MA; Lehmann A; Surdacka A
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment.
    Kaguelidou F; Alberti C; Castanet M; Guitteny MA; Czernichow P; Léger J;
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3817-26. PubMed ID: 18628515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive effects of antithyroid drugs.
    Ratanachaiyavong S; McGregor AM
    Clin Endocrinol Metab; 1985 May; 14(2):449-66. PubMed ID: 2415278
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.
    Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP
    Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
    Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
    Glinoer D; de Nayer P; Bex M;
    Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational management of thyroid auto-immune disease.
    Adams DD
    N Z Med J; 1974 Dec; 80(529):486-9. PubMed ID: 4141486
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basedow disease hyperthyroidism--is there a therapeutic standard? Conservative therapy].
    Schumm-Draeger PM
    Zentralbl Chir; 1997; 122(4):224-6. PubMed ID: 9221630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical phenotype of Graves' disease occurring as an isolated condition or in association with other autoimmune diseases.
    Rotondi M; Virili C; Pinto S; Coperchini F; Croce L; Brusca N; Centanni M; Chiovato L
    J Endocrinol Invest; 2020 Feb; 43(2):157-162. PubMed ID: 31407208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.